congestive heart failure – Page 7 – Communicable Diseases Research

Effect of COVID-19 on the Organs

Anesthesiology

Published on 2020-08-032022-10-31
Journal: Cureus [Category] COVID-19,

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial

Study Protocol

Published on 2020-07-312022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 24 hour addition Administered adverse event all subject allocation sequence Analysis antiviral activity Antiviral effect Arm arrhythmia Asymptomatic bradycardia can be used carried Cell Chronic kidney disease clinical Cluster Clusters Comorbidity Compliance conducted congestive heart failure Contact contraindication Coronaviruses covariates COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 patient COVID-19 patients COVID-19 symptom Data monitoring committee database deficiency defined Department diabete diagnostic dialysis disease dissemination diuretics dose drug Drug-drug interactions during treatment early treatment Efficacy element eligible endosomal pH ENhance enrolled Epidemic Epidemiology equation EudraCT evaluate Evidence expected Factor female Final G6PD Generalized generate Glucose-6-phosphate glycosylation group Healthcare professional Hydroxychloroquine hydroxychloroquine/chloroquine identify in vitro in vivo inclusion criteria independent index index case index cases Infection interim analysis involved IRCCS ischemic heart disease Italian region Italy Loading dose male malignancy medication mental illness mild symptoms neurological number objective observation open label oropharyngeal swab outcome parallel group participant Patient patients with COVID-19 Paucisymptomatic performed positive PCR test Prevent prevention prevention of COVID-19 Prophylaxis proportion Proteins protocol protocol amendment Public QT prolongation randomization Randomized Randomized controlled clinical trial Randomized controlled trial reached receive recorded recruited reduced reduction in Registered reported required risk Sample size SARS-CoV-2 shown Standard status stratified Studio Study protocol subject subjects Support Swab Symptom symptomatic syndrome Tablet therapeutic approaches therapy Toxicity treat treated Treatment Trial trial protocol ventricular viral surface virus virus infection website with COVID-19
[DOI] 10.1186/s13063-020-04527-4 PMC 바로가기 [Article Type] Study Protocol

Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain

Article

Published on 2020-07-172022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

[키워드] Acute myocardial infarction adverse outcomes Analysis baseline chronic Chronic diseases Clinical characteristics clinical factor clinical variables Cohort Comorbidities Comorbidity conducted congestive heart failure coronavirus disease COVID-19 COVID-19 disease described diabetes drug drugs Evidence explain explained Factors Gender higher risk individual Infection laboratory-confirmed likelihood Logistic regression medication men men and women Mortality Multimorbidity old age Patient performed Research Result retrospective cohort study Risk factors socio-demographic Spain specific disease stratified by sex women
[DOI] 10.3390/ijerph17145171 PMC 바로가기 [Article Type] Article

A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial”

Letter

Published on 2020-06-262022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Acute respiratory failure Administered Admission Adverse age Aneurysm Antibiotics atherosclerotic baseline blind blood pressure Brain cardiovascular disease carotid cerebrovascular accident cervical spine chronic clinical trial Complete congestive heart failure Consent control group Controlled trial Coronary artery disease cough COVID-19 criteria current cytokine Cytokine storm Day decrease Delay Disabled disease dissemination distress dose electrical element eligible enrolled evaluate expected Follow-up Gender growth Healthcare provider hemorrhage history hospital hospital discharge ICU admission Informed Initiation interleukin interleukin 6 Intervention less mechanical ventilation mechanical ventilator Mild moderate Mortality Myocardial infarction nerve stimulation number O2 Saturation objective occur Older open label outcome oxygen Oxygen level Oxygen therapy parallel group participant Patient patients with moderate per day persist positive prophylactically protocol pulmonary randomisation randomised randomised controlled randomised controlled trial randomization Randomized recruited recruitment reduce reduction regimen Registered required Research respiratory Respiratory failure Sample size Sapphire saturation second dose secondary severity Shortness of breath SOC Spain Standard Standard of care status storm stratified study group Study protocol subject supplemental oxygen supplemental oxygen requirement tested trauma Treatment tumor necrosis factor tumors uncontrolled Vague neurostimulation Valencia Ventilation ventilatory support website women
[DOI] 10.1186/s13063-020-04486-w PMC 바로가기 [Article Type] Letter

Infective Endocarditis in Northeastern Thailand

Dispatch

Published on 2014-03-012023-05-31
Journal: Emerging Infectious Diseases [Category] Fulltext, 조류인플루엔자,

[키워드] antimicrobial drugs Bacteria Bartonella congestive heart failure Coxiella burnetii heart valve Infective endocarditis Q fever rheumatic heart disease Thailand Viridans streptococci zoonoses
[DOI] 10.3201/eid2003.131059 PMC 바로가기 [Article Type] Dispatch